Synthesis and biological evaluation of isoxazoline derivatives as potent M1 muscarinic acetylcholine receptor agonists

被引:10
作者
Huang, Minghua [1 ,3 ]
Suk, Dae-Hwan [2 ]
Cho, Nam-Chul [2 ,4 ]
Bhattarai, Deepak [2 ,3 ]
Kang, Soon Bang [2 ]
Kim, Youseung [2 ]
Pae, Ae Nim [2 ]
Rhim, Hyewhon [1 ,3 ]
Keum, Gyochang [2 ,3 ]
机构
[1] Korea Inst Sci & Technol, Ctr Neurosci, Brain Sci Inst, Seoul 136791, South Korea
[2] Korea Inst Sci & Technol, Ctr Neuromed, Brain Sci Inst, Seoul 136791, South Korea
[3] Univ Sci & Technol, Dept Biomol Sci, Taejon 305350, South Korea
[4] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea
关键词
mAChR receptor; M-1; agonist; 2-Pyrrolidone; Isoxazoline; Amyloid precursor protein; AMYLOID PRECURSOR PROTEIN; ALLOSTERIC MODULATION; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; ACTIVATION; BETA; PHARMACOLOGY; COGNITION; EMPHASIS; KINASE;
D O I
10.1016/j.bmcl.2015.02.012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of azacyclic compounds substituted with isoxazole and 5-substituted isoxazolines were synthesized as acyclic modifications of the oxime class M-1 mACh receptor agonist. Among them, 3-(tetrahydropyrin-3-yl)-5-(2-pyrrolodin-1-yl) isoxazoline compound 4f displayed potent and selective M1 mACh receptor agonist activity in the functional calcium mobilization assay (EC50 = 31 nM). Introduction of 2-pyrrolidinone and 3-tetrahydropyridine groups are pivotal to the high potency. Moreover, 4f was found to facilitate non-amyloidogenic amyloid precursor protein (APP) processing by significantly increasing ERK1/2 phosphorylation and sAPP alpha secretion, known disease-modifying effects related to M1 mAChR agonists in Alzheimer's disease (AD). (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1546 / 1551
页数:6
相关论文
共 50 条
  • [21] Enhanced arecoline derivatives as muscarinic acetylcholine receptor M1 ligands for potential application as PET radiotracers
    Ozenil, Marius
    Pacher, Katharina
    Balber, Theresa
    Vraka, Chrysoula
    Roller, Alexander
    Holzer, Wolfgang
    Spreitzer, Helmut
    Mitterhauser, Markus
    Wadsak, Wolfgang
    Hacker, Marcus
    Pichler, Verena
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 204
  • [22] Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes
    Maeda, Shoji
    Qu, Qianhui
    Robertson, Michael J.
    Skiniotis, Georgios
    Kobilka, Brian K.
    SCIENCE, 2019, 364 (6440) : 552 - +
  • [23] 4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor
    Mistry, Shailesh N.
    Joerg, Manuela
    Lim, Herman
    Vinh, Natalie B.
    Sexton, Patrick M.
    Capuano, Ben
    Christopoulos, Arthur
    Lane, J. Robert
    Scammells, Peter J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (01) : 388 - 409
  • [24] Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
    Ma, Lei
    Seager, Matthew
    Wittmann, Marion
    Jacobson, Marlene
    Bickel, Denise
    Burno, Maryann
    Jones, Keith
    Graufelds, Valerie Kuzmick
    Xu, Guangping
    Pearson, Michelle
    McCampbell, Alexander
    Gaspar, Renee
    Shughrue, Paul
    Danziger, Andrew
    Regan, Christopher
    Flick, Rose
    Pascarella, Danette
    Garson, Susan
    Doran, Scott
    Kreatsoulas, Constantine
    Veng, Lone
    Lindsley, Craig W.
    Shipe, William
    Kuduk, Scott
    Sur, Cyrille
    Kinney, Gene
    Seabrook, Guy R.
    Ray, William J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (37) : 15950 - 15955
  • [25] Restoring Agonist Function at a Chemogenetically Modified M1 Muscarinic Acetylcholine Receptor
    Khajehali, Elham
    Bradley, Sophie
    van der Westhuizen, Emma T.
    Molloy, Colin
    Valant, Celine
    Finlayson, Lisa
    Lindsley, Craig W.
    Sexton, Patrick M.
    Tobin, Andrew B.
    Christopoulos, Arthur
    ACS CHEMICAL NEUROSCIENCE, 2020, 11 (24): : 4270 - 4279
  • [26] Molecular Mechanisms of Bitopic Ligand Engagement with the M1 Muscarinic Acetylcholine Receptor
    Keov, Peter
    Lopez, Laura
    Devine, Shane M.
    Valant, Celine
    Lane, J. Robert
    Scammells, Peter J.
    Sexton, Patrick M.
    Christopoulos, Arthur
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (34) : 23817 - 23837
  • [27] Enhancing remyelination in multiple sclerosis via M1 muscarinic acetylcholine receptor
    Chen, Keren
    Park, Eunyoung
    Abd-Elrahman, Khaled S.
    MOLECULAR PHARMACOLOGY, 2025, 107 (04)
  • [28] M1 muscarinic agonists: Their potential in treatment and as disease-modifying agents in Alzheimer's disease
    Fisher, A
    DRUG DEVELOPMENT RESEARCH, 2000, 50 (3-4) : 291 - 297
  • [29] An Antibody Biosensor Establishes the Activation of the M1 Muscarinic Acetylcholine Receptor during Learning and Memory
    Butcher, Adrian J.
    Bradley, Sophie J.
    Prihandoko, Rudi
    Brooke, Simon M.
    Mogg, Adrian
    Bourgognon, Julie-Myrtille
    Macedo-Hatch, Timothy
    Edwards, Jennifer M.
    Bottrill, Andrew R.
    Challiss, R. A. John
    Broad, Lisa M.
    Felder, Christian C.
    Tobin, Andrew B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (17) : 8862 - 8875
  • [30] Toward activated homology models of the human M1 muscarinic acetylcholine receptor
    Chin, Sek Peng
    Buckle, Michael J. C.
    Chalmers, David K.
    Yuriev, Elizabeth
    Doughty, Stephen W.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2014, 49 : 91 - 98